Scientists are looking toward microglia cells as therapeutic targets for Alzheimer’s. Microglia, known as the janitors of our brains, are responsible for clearing harmful…
Using the blue device (pictured) that performs the ultrasensitive proximity extension assay technology, Professor Nancy Ip Yuk-Yu and her team have developed a blood…
Researchers share insights on the infectious theory of Alzheimer’s—the idea viruses and bacteria may cause Alzheimer’s. Clinical trials are underway to test this theory….
Swimming gives your brain a boost – but scientists don’t know yet why it’s better than other aerobic activities. Seena Mathew, assistant professor of biology…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Image courtesy of Fayron Epps. One day,…
Alzheimer’s is a complex disease, and studies that follow participants over extended periods of time can gather troves of data on the progression of…
Bad news arrived recently for the constantly caffeinated: Researchers recently found evidence that drinking more than six cups of coffee a day could shrink…
From the nature of Alzheimer’s to the solutions available for controlling it, here are five common misconceptions to dispel. Alzheimer’s is the sixth leading…
Scientists still don’t know why some people develop Alzheimer’s and others don’t. But while we may not fully understand the causes of Alzheimer’s, researchers…
Cassava Sciences revealed positive clinical data from their simufilam trial, a potentially disease-modifying therapy for treating Alzheimer’s. Their preliminary study showed that simufilam significantly…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Sheri Yarbrough sat across from her parents…
Since the novel coronavirus began raging across the world last year, scientists have come to understand that patients infected with SARS-CoV-2, the virus responsible…
In Being Patient’s LiveTalk series, Dr. David Weidman, associate medical director for research at the Banner Alzheimer’s Institute, shares insights on Eli Lilly’s investigational Alzheimer’s…
Roughly one in 10 people worldwide, or over 700 million people, will experience hearing loss by 2050, and research suggests it is the leading…
Shreya Mcleod, a titled sports and musculoskeletal physiotherapist, and James F. Donnelly, a lecturer and researcher in Psychology at Southern Cross University, share insights…